Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biotech Growth Trust (The)LSE:BIOG -0.62%39 Buyback Yield % is 24.32 as of Jul. 16, 2026, which is 217% above its 10-year median of 7.67. GuruFocus rates LSE:BIOG with a GF Score™ of 39/100. The stock has 2 warning signs investors should review. Among 767 Asset Management companies, Biotech Growth Trust (The) ranks better than 95.05% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:BIOG vs BLK, BX, KKR: Buyback Yield % Comparison
For the Asset Management subindustry, Biotech Growth Trust (The)'s Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotech Growth Trust (The) Buyback Yield % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Biotech Growth Trust (The)'s Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotech Growth Trust (The) (LSE:BIOG) has a Buyback Yield % of 24.32 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Biotech Growth Trust (The) and its competitors. This is 217% above median its historical median of 7.67. According to the industry distribution chart, Biotech Growth Trust (The) ranks #38 out of 767 companies in the Asset Management industry, placing it in the top 5%.
Is Biotech Growth Trust (The)'s Buyback Yield % too high?
Biotech Growth Trust (The)'s current Buyback Yield % of 24.32 is 217% above median its 10-year median of 7.67. The Asset Management industry median Buyback Yield % is 0.21. Biotech Growth Trust (The)'s value of 24.32 is 11481% above this industry median. Based on the distribution chart, Biotech Growth Trust (The) ranks #38 out of 767 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Biotech Growth Trust (The) has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Biotech Growth Trust (The)'s Buyback Yield % compare to BLK and BX?
According to the Asset Management industry distribution chart, Biotech Growth Trust (The) ranks #38 out of 767 companies for Buyback Yield %. This places Biotech Growth Trust (The) in the top 5% of its industry — outperforming the majority of peers. The industry median Buyback Yield % is 0.21. Biotech Growth Trust (The)'s value of 24.32 is 11481% above this benchmark. While the company's 10-year median is 7.67 vs. the industry median of 0.21, Biotech Growth Trust (The) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for an Asset Management company?
The median Buyback Yield % among Asset Management companies is 0.21, based on 767 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biotech Growth Trust (The)'s current Buyback Yield % of 24.32 is 11481% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Biotech Growth Trust (The) and its competitors. For the Asset Management industry, the median Buyback Yield % is 0.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotech Growth Trust (The)'s current Buyback Yield % is 24.32, which is 217% above median its own 10-year median of 7.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotech Growth Trust (The) stock overvalued right now?
Biotech Growth Trust (The) (LSE:BIOG) has a current Buyback Yield % of 24.32. The current Buyback Yield % is 24.32, which is 217% above median its 10-year median of 7.67 and 11481% above the Asset Management industry median of 0.21. Biotech Growth Trust (The)'s overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Biotech Growth Trust (The) (LSE:BIOG), the current Buyback Yield % is 24.32 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biotech Growth Trust (The) PLC is an externally managed investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world.
39GF Score
Get the complete analysis for LSE:BIOG
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BIOG has been successfully added to your 
